Venlafaxine Hydrochloride
Product Images NDC 70934-349

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Venlafaxine Hydrochloride (NDC 70934-349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (70934 349 30 Rev A 05 19)

Label (70934 349 30   Rev A 05 19)
This is a prescription drug for Venlafaxine Hydrochloride Extended-Release capsules of 75mg with a pack size of 30. The National Drug Code is 70934349-30. The text lacks useful information and structure, suggesting that the process did not occur successfully.*
FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 01)

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 01)
This is a list of drugs and their interactions with each other and a specific enzyme called CYP2D6. It also includes information about the analyte venlafaxine and PK fold changes. The recommendations for use with these drugs vary and include avoiding concomitant use, using with caution in certain populations, and monitoring blood pressure. There is no further context or explanation provided.*
FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 02)

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 02)
This is a list of drugs and their potential interactions and effects when used concomitantly. The drugs include ethanol, diazepam, alprazolam, indinavir, metoprolol, risperidone, imipramine, haloperidol, caffeine, and lithium. The text provides information regarding the Analyte PKFold Change and 90% CRecommendation for each drug, as well as the potential effects on Cmax and Auc. There is a note that suggests caution and monitoring of blood pressure when using certain drugs together. Overall, this text provides insight into potential drug interactions and the need for careful consideration when using multiple medications concurrently.*
FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 03)

FDA Label Image

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 04)

Venlafaxine Hydrochloride Extended-release Capsules, Usp (719c77d6 C5bc 4d70 89b1 E84f1bf4b9dd 04)
The text is a combination of letters and numbers ("eHCI" and "H4C0 C") followed by the name of a substance ("venlafaxine hydrochloride"). Therefore, it seems like the text is referring to a chemical compound or medication. Specifically, "venlafaxine hydrochloride" is a prescription drug used to treat depression, anxiety, and panic disorder. However, the first two parts of the text ("eHCI" and "H4C0 C") do not provide any additional information and may be errors from .*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.